We are live on ! Find out more
TECH icon

Bio-Techne

393 hedge funds and large institutions have $9.65B invested in Bio-Techne in 2020 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 133 increasing their positions, 138 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more call options, than puts

Call options by funds: $27.4M | Put options by funds: $10.9M

79% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 38

38% more capital invested

Capital invested by funds: $6.99B → $9.65B (+$2.66B)

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

7% more funds holding

Funds holding: 368393 (+25)

4% less repeat investments, than reductions

Existing positions increased: 133 | Existing positions reduced: 138

2.38% less ownership

Funds ownership: 384.73%382.35% (-2.4%)

Holders
393
Holders Change
+25
Holders Change %
+6.79%
% of All Funds
8.04%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.12%
New
68
Increased
133
Reduced
138
Closed
38
Calls
$27.4M
Puts
$10.9M
Net Calls
+$16.5M
Net Calls Change
+$25.3M

TECH Hedge Fund Activity: Q2 2020 in Review

393 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2020, worth a combined $9.65B — up 38% from $6.99B a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new TECH positions and 38 closed out — a net gain of 30 holders — while 133 added to existing stakes and 138 trimmed.

The largest buyer was BlackRock, adding an estimated $244M. The largest seller was Wellington Management Group, cutting an estimated $109M.

  • 393 institutional investors held Bio-Techne (TECH) as of Q2 2020, up from 368 in Q1 2020.
  • Funds reported $9.65B of Bio-Techne stock for Q2 2020, up 38% quarter-over-quarter.
  • 68 funds opened new Bio-Techne positions in Q2 2020 and 38 closed out, a net change of +30 holders.
  • The largest Bio-Techne buyer in Q2 2020 was BlackRock, an estimated $244M added.
  • The largest Bio-Techne seller in Q2 2020 was Wellington Management Group, an estimated $109M sold.

Based on aggregated 13F filings for Q2 2020.